⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRVS News
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Comprehensive Report on Renal Cancer Pipeline Insights for 2026: Over 80 Pipeline Drugs and 75+ Companies Analyzed
globenewswire.com
EXEL
CRVS
BIIB
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
globenewswire.com
CRVS
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
globenewswire.com
CRVS
Form 8-K
sec.gov
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
CRVS